Literature DB >> 9714008

45,X/46,X,idic(Yq) mosaicism: clinical, cytogenetic, and molecular studies in four individuals.

M Teraoka1, K Narahara, Y Yokoyama, K Tsuji, K Kikkawa, S Ito, K Koyama, Y Seino.   

Abstract

45,X/46,X,idic(Yq) mosaicism is associated with a variety of sex phenotypes, including Ullrich-Turner syndrome (UTS), intersexuality, and complete male. It remains unclear whether the phenotypic variability results from a dilutional effect by the 45,X cell line in the primordial gonad or an abnormality of the SRY gene (SRY). We conducted cytogenetic and molecular studies on four patients with such mosaicism, two of whom had a complete male phenotype and two who had UTS. Chromosome analyses showed that the frequency of cells carrying an idic(Yq) chromosome in peripheral blood lymphocytes and skin fibroblasts was not related to the given sex phenotype. The SRY, PABY, and ZFY genes were present in all four patients. A fluorescence in situ hybridization (FISH) study showed that both a patient with a complete male phenotype and another with UTS had duplicate copies of SRY in their idic(Yq) chromosomes, whereas a patient with UTS had a single copy of the gene. These findings suggested that the coexisting 45,X cell line is more influential on the determination of the sex phenotype in individuals with 45,X/ 46,X,idic(Yq) mosaicism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714008     DOI: 10.1002/(sici)1096-8628(19980806)78:5<424::aid-ajmg6>3.0.co;2-l

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  2 in total

1.  Startling mosaicism of the Y-chromosome and tandem duplication of the SRY and DAZ genes in patients with Turner Syndrome.

Authors:  Sanjay Premi; Jyoti Srivastava; Ganesan Panneer; Sher Ali
Journal:  PLoS One       Date:  2008-11-24       Impact factor: 3.240

2.  Clinical, cytogenetic, and molecular findings of isodicentric Y chromosomes.

Authors:  Yang Yang; Wang Hao
Journal:  Mol Cytogenet       Date:  2019-12-27       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.